These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma]. Luo YL, Chen H, Peng SG, Lin JH, Huang PY. Zhonghua Yi Xue Za Zhi; 2013 Nov 26; 93(44):3516-9. PubMed ID: 24521892 [Abstract] [Full Text] [Related]
7. Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma. Cai YL, Li J, Lu AY, Zheng YM, Zhong WM, Wang W, Gao JQ, Zeng H, Cheng JR, Tang MZ. Asian Pac J Cancer Prev; 2014 Nov 26; 15(5):2001-6. PubMed ID: 24716925 [Abstract] [Full Text] [Related]
9. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma. Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W. Int J Infect Dis; 2014 Aug 26; 25():110-5. PubMed ID: 24878579 [Abstract] [Full Text] [Related]
11. [Evaluation of combined determinations of Epstein-Barr virus antibodies for nasopharyngeal carcinoma assessed with receiver operating characteristic curve based on logistic regression]. Cai YL, Zheng YM, Cheng JR, Li J, Mo YK, Zhong QY. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct 26; 23(5):384-7. PubMed ID: 20387494 [Abstract] [Full Text] [Related]
12. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma. Tiwawech D, Srivatanakul P, Karaluk A, Ishida T. Asian Pac J Cancer Prev; 2003 Oct 26; 4(2):113-8. PubMed ID: 12875623 [Abstract] [Full Text] [Related]
16. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma. Jiang SQ, Liu Q. Ai Zheng; 2009 Feb 26; 28(2):177-80. PubMed ID: 19550133 [Abstract] [Full Text] [Related]
18. EA-D p45-IgG as a potential biomarker for nasopharyngeal carcinoma diagnosis. Chen H, Luo YL, Zhang L, Tian LZ, Feng ZT, Liu WL. Asian Pac J Cancer Prev; 2013 Feb 26; 14(12):7433-8. PubMed ID: 24460315 [Abstract] [Full Text] [Related]
19. Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay. Li Y, Wang K, Yin SK, Zheng HL, Min DL. Genet Mol Res; 2016 Mar 18; 15(1):. PubMed ID: 27050964 [Abstract] [Full Text] [Related]
20. [Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma]. Yi B, Gu YL, Zong YS, Cheng WM, Ji MF. Ai Zheng; 2009 Aug 18; 28(8):822-6. PubMed ID: 19664327 [Abstract] [Full Text] [Related] Page: [Next] [New Search]